Deemea provides an AI-powered imaging solution designed to enhance the efficiency and reliability of imaging data management in clinical research. The platform offers tools for smart data collection, structuring, and interpretation, while ensuring compliance with regulatory standards for personal health data.

Deemea

Deemea is a digital health company with expertise in the AI-driven structuring and analysis of medical data. Our specialization in imaging data processing has led us to develop and deploy a collaborative platform for medical data analysis, aimed at expediting biopharmaceutical and medical device clinical studies. Our innovative proprietary technology powers a multi-modal, multi-centric platform that prioritizes the security, privacy, and sovereignty of medical data, as well as the sustainability of healthcare facilities. Deemea empowers data-driven research, ultimately expediting patients' access to innovative therapies.

AGORANOV

🤔 A little quiz to celebrate the work of orthopedists and the start of UEFA Euro 2024.

Eur⚽thopedics!

🔁 Last week, the answer was: N'GOLO KANTÉ!

🃏Who’s who?

I am part of the Italian national team.

After a cruciate ligament tear in January 2022, I underwent surgery to reconstruct my anterior cruciate ligament in my left knee. A documentary on my road to recovery has been released in 2023.

❔ Who am I...?

🗳 Vote with an emoji reaction!
We’ll answer next week with the next quiz
#EURO2024

🔁 Replay

🚀 Last Tuesday, we were at Campus Live, the 3rd annual event of PariSanté Campus 🚀

🔹 France position itself as a European leader in innovation, contributing to the success of the healthcare innovation ecosystem. Lise ALTER (Agence de l'innovation en santé)
🔹 Clinical trials in oncology have quadrupled since the 2000s, Frédéric Collet (Filière Intelligence Artificielle & Cancers)
🔹 80-90% of our time is spent collecting data. Benjamin Besse (Gustave Roussy)

📍 Databases need to be enriched and built on a larger scale. We need agnostic teams to handle the fusion of all types of data, with multimodal AI. Benjamin Besse (Gustave Roussy)

📍We must now focus on data formatting, mixing data from different formats and sources, thinking AI and healthcare to improve the quality of patient care. fabrice lenglart (Direction des statistiques, des études et de la recherche - DSER)

🚩The challenges to accelerate clinical research enlightened by Lise ALTER:
 1️⃣ mobilizing AI
 2️⃣ removing technical and legal obstacles
 3️⃣ connecting academic, clinical, industrial and investor players.

🤝 Let’s work together to address our healthcare system challenges with the help of AI

🙏 Thanks to PariSanté Campus and Antoine Tesniere for this tremendous opportunity to connect with our ecosystem!

#Deemea #clinicalresearch #RWE #PariSantéCampus #CampusLive

Charlotte Pouchy Mael Mertad Maxime Cervino Stéphanie Olas Benjamin Besse sophie VERNET Emmanuel Barillot Kathryn ERNECQ Marie Cambot Olivier Bignolais Pauline Poccioni Lara Dirian, Ph.D

🤔 A little quiz to celebrate the work of orthopedists and the start of UEFA Euro 2024.

Eur⚽thopedics !

🃏 Who’s who?

I am part of the French national team.
I had a hamstring injury in August 2022, which required orthopedic surgery that allowed me to regain my abilities.

❔ Who am I...?

🗳 Vote with an emoji reaction!

We’ll answer next week with the next quiz
#EURO2024

What a week for DEEMEA!
🚀AFCRO symposium on real world data next week! 🚀

We are thrilled to attend the annual AFCROs symposium on Real World Data, in Paris!
📅 June 20, 2024

Looking forward to presenting our use cases of our work!
If your are attending this conference, let's connect with our experts!

#Deemea #clinicalresearch #RWE #medicalimaging #RWD #AFCRO

🚀 HLTH Europe 2024 next week! 

We are thrilled to attend the 1st European edition of HLTH Europe, in Amsterdam!
📅 June 17-19, 2024

Looking forward to reconnecting and making new inspiring connections HLTH with numerous international healthcare experts ; and sharing our vision for our European development.

Do you plan to attend HLTH Europe?
If you are looking for an Al platform to accelerate your biomedical research, let's connect.

📣 Our CEO Charlotte Pouchy will be part of an exciting roundtable discussion: "Pioneers of Health: Showcasing Future4Care’s Rising Stars"
📍Tuesday, June 18th from 4:30-5:00PM CEST, Capgemini Life Sciences and Healthcare booth.
🙏 Thanks to Capgemini Life Sciences and Healthcare and Future4Care!

👉 http://europe.hlth.com 

#Deemea #clinicalresearch #RWE #medicalimaging #hlth

Metric
Company Name	Deemea
Symbol
MSH ID	COM:DEEMEA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Technology
Country	FR
Stage
Employee Count	14
Website	deemea.com
LinkedIn	deemea
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DEEMEA

Deemea

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue